fanta.bio Sample: CNhs10634
18081 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| HIF1A SRX11007095 | HK-2 Kidney | 2283 / 16449 (13.9%) | 898 / 164490 (0.5%) | −324.0 | −324.0 | 25.42 |
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1067 / 16449 (6.5%) | 456 / 164490 (0.3%) | −324.0 | −324.0 | 23.40 |
| HIF1A SRX20663235 | HK-2 Kidney | 544 / 16449 (3.3%) | 250 / 164490 (0.2%) | −324.0 | −324.0 | 21.76 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1640 / 16449 (10.0%) | 798 / 164490 (0.5%) | −324.0 | −324.0 | 20.55 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2331 / 16449 (14.2%) | 1156 / 164490 (0.7%) | −324.0 | −324.0 | 20.16 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2266 / 16449 (13.8%) | 1134 / 164490 (0.7%) | −324.0 | −324.0 | 19.98 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1555 / 16449 (9.5%) | 791 / 164490 (0.5%) | −324.0 | −324.0 | 19.66 |
| SCML2 SRX644728 | 293 Kidney | 1365 / 16449 (8.3%) | 764 / 164490 (0.5%) | −324.0 | −324.0 | 17.87 |
| FOXP1 SRX736067 | LNCAP Prostate | 1613 / 16449 (9.8%) | 1223 / 164490 (0.7%) | −324.0 | −324.0 | 13.19 |
| MED1 SRX9419945 | BT-474 Breast | 3595 / 16449 (21.9%) | 2797 / 164490 (1.7%) | −324.0 | −324.0 | 12.85 |
| BRD4 SRX9419935 | BT-474 Breast | 3507 / 16449 (21.3%) | 2791 / 164490 (1.7%) | −324.0 | −324.0 | 12.57 |
| MED1 SRX9419944 | BT-474 Breast | 3480 / 16449 (21.2%) | 2779 / 164490 (1.7%) | −324.0 | −324.0 | 12.52 |
| BRD4 SRX9419936 | BT-474 Breast | 3635 / 16449 (22.1%) | 2947 / 164490 (1.8%) | −324.0 | −324.0 | 12.33 |
| MED1 SRX9419946 | BT-474 Breast | 3605 / 16449 (21.9%) | 2971 / 164490 (1.8%) | −324.0 | −324.0 | 12.13 |
| BRD4 SRX9419938 | BT-474 Breast | 3565 / 16449 (21.7%) | 2973 / 164490 (1.8%) | −324.0 | −324.0 | 11.99 |
| BRD4 SRX9419937 | BT-474 Breast | 3437 / 16449 (20.9%) | 2868 / 164490 (1.7%) | −324.0 | −324.0 | 11.98 |
| MED1 SRX9419947 | BT-474 Breast | 3500 / 16449 (21.3%) | 2926 / 164490 (1.8%) | −324.0 | −324.0 | 11.96 |
| MYH11 SRX265221 | ME-1 Blood | 763 / 16449 (4.6%) | 666 / 164490 (0.4%) | −324.0 | −324.0 | 11.46 |
| EZH2 SRX2146136 | LNCAP Prostate | 8000 / 16449 (48.6%) | 7842 / 164490 (4.8%) | −324.0 | −324.0 | 10.20 |
| BRD4 SRX736201 | 90-8TL Neural | 5755 / 16449 (35.0%) | 6615 / 164490 (4.0%) | −324.0 | −324.0 | 8.70 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1726 / 16449 (10.5%) | 2667 / 164490 (1.6%) | −324.0 | −324.0 | 6.47 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1691 / 16449 (10.3%) | 3436 / 164490 (2.1%) | −324.0 | −324.0 | 4.92 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 2156 / 16449 (13.1%) | 4700 / 164490 (2.9%) | −324.0 | −324.0 | 4.59 |
| KMT2A SRX2323891 | 293 Kidney | 1312 / 16449 (8.0%) | 3103 / 164490 (1.9%) | −324.0 | −324.0 | 4.23 |
| AGO2 SRX6783957 | Hep G2 Liver | 1650 / 16449 (10.0%) | 4211 / 164490 (2.6%) | −324.0 | −324.0 | 3.92 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1952 / 16449 (11.9%) | 4998 / 164490 (3.0%) | −324.0 | −324.0 | 3.91 |
| AGO2 SRX6783958 | Hep G2 Liver | 1615 / 16449 (9.8%) | 4161 / 164490 (2.5%) | −324.0 | −324.0 | 3.88 |
| BRD1 SRX286203 | RKO Digestive tract | 1453 / 16449 (8.8%) | 3903 / 164490 (2.4%) | −324.0 | −324.0 | 3.72 |
| Epitope tags SRX10549776 | K-562 Blood | 1765 / 16449 (10.7%) | 4836 / 164490 (2.9%) | −324.0 | −324.0 | 3.65 |
| AGO2 SRX4708039 | Hep G2 Liver | 2541 / 16449 (15.4%) | 7072 / 164490 (4.3%) | −324.0 | −324.0 | 3.59 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 1585 / 16449 (9.6%) | 4550 / 164490 (2.8%) | −324.0 | −324.0 | 3.48 |
| KAT7 SRX101303 | RKO Digestive tract | 1642 / 16449 (10.0%) | 4838 / 164490 (2.9%) | −324.0 | −324.0 | 3.39 |
| BRPF3 SRX796086 | RKO Digestive tract | 1786 / 16449 (10.9%) | 5524 / 164490 (3.4%) | −324.0 | −324.0 | 3.23 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 2085 / 16449 (12.7%) | 6454 / 164490 (3.9%) | −324.0 | −324.0 | 3.23 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 2302 / 16449 (14.0%) | 7212 / 164490 (4.4%) | −324.0 | −324.0 | 3.19 |
| ERG SRX063921 | K-562 Blood | 1940 / 16449 (11.8%) | 6091 / 164490 (3.7%) | −324.0 | −324.0 | 3.19 |
| BRPF3 SRX796084 | RKO Digestive tract | 1853 / 16449 (11.3%) | 5835 / 164490 (3.5%) | −324.0 | −324.0 | 3.18 |
| SREBF2 SRX5359048 | HCC70 Breast | 2242 / 16449 (13.6%) | 7119 / 164490 (4.3%) | −324.0 | −324.0 | 3.15 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 2141 / 16449 (13.0%) | 6820 / 164490 (4.1%) | −324.0 | −324.0 | 3.14 |
| CXXC1 SRX1424886 | SEM Blood | 1830 / 16449 (11.1%) | 5873 / 164490 (3.6%) | −324.0 | −324.0 | 3.12 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 2468 / 16449 (15.0%) | 7923 / 164490 (4.8%) | −324.0 | −324.0 | 3.11 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 2026 / 16449 (12.3%) | 6540 / 164490 (4.0%) | −324.0 | −324.0 | 3.10 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 2300 / 16449 (14.0%) | 7454 / 164490 (4.5%) | −324.0 | −324.0 | 3.09 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 2580 / 16449 (15.7%) | 8432 / 164490 (5.1%) | −324.0 | −324.0 | 3.06 |
| ERG SRX063922 | K-562 Blood | 1990 / 16449 (12.1%) | 6524 / 164490 (4.0%) | −324.0 | −324.0 | 3.05 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2753 / 16449 (16.7%) | 9037 / 164490 (5.5%) | −324.0 | −324.0 | 3.05 |
| PHF6 SRX11508321 | G-401 Kidney | 1948 / 16449 (11.8%) | 6452 / 164490 (3.9%) | −324.0 | −324.0 | 3.02 |
| MECOM SRX23677884 | HNT-34 Blood | 2275 / 16449 (13.8%) | 7548 / 164490 (4.6%) | −324.0 | −324.0 | 3.01 |
| BMI1 SRX7196721 | SF8628 Neural | 2228 / 16449 (13.5%) | 7401 / 164490 (4.5%) | −324.0 | −324.0 | 3.01 |
| MECOM SRX23677885 | HNT-34 Blood | 2301 / 16449 (14.0%) | 7645 / 164490 (4.6%) | −324.0 | −324.0 | 3.01 |
| PTEN SRX5416007 | SMMC-7721 Liver | 2375 / 16449 (14.4%) | 7898 / 164490 (4.8%) | −324.0 | −324.0 | 3.01 |
| CDYL2 SRX8321653 | MCF-7 Breast | 2421 / 16449 (14.7%) | 8103 / 164490 (4.9%) | −324.0 | −324.0 | 2.99 |
| CHD6 SRX17709200 | C4-2 Prostate | 1964 / 16449 (11.9%) | 6604 / 164490 (4.0%) | −324.0 | −324.0 | 2.97 |
| MEAF6 DRX234811 | 293 Kidney | 2086 / 16449 (12.7%) | 7024 / 164490 (4.3%) | −324.0 | −324.0 | 2.97 |
| ZFX SRX7805372 | 293 Kidney | 1927 / 16449 (11.7%) | 6490 / 164490 (3.9%) | −324.0 | −324.0 | 2.97 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 2349 / 16449 (14.3%) | 7914 / 164490 (4.8%) | −324.0 | −324.0 | 2.97 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 2557 / 16449 (15.5%) | 8642 / 164490 (5.3%) | −324.0 | −324.0 | 2.96 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 2100 / 16449 (12.8%) | 7123 / 164490 (4.3%) | −324.0 | −324.0 | 2.95 |
| MECOM SRX23677891 | HNT-34 Blood | 2306 / 16449 (14.0%) | 8090 / 164490 (4.9%) | −324.0 | −324.0 | 2.85 |
| MECOM SRX23677890 | HNT-34 Blood | 2292 / 16449 (13.9%) | 8113 / 164490 (4.9%) | −324.0 | −324.0 | 2.83 |
| MECOM SRX23677897 | HNT-34 Blood | 2692 / 16449 (16.4%) | 9589 / 164490 (5.8%) | −324.0 | −324.0 | 2.81 |
| MECOM SRX23677896 | HNT-34 Blood | 2780 / 16449 (16.9%) | 10021 / 164490 (6.1%) | −324.0 | −324.0 | 2.77 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 2333 / 16449 (14.2%) | 8575 / 164490 (5.2%) | −324.0 | −324.0 | 2.72 |
| KMT2A SRX2281249 | SEM Blood | 2411 / 16449 (14.7%) | 9079 / 164490 (5.5%) | −324.0 | −324.0 | 2.66 |
| MITF SRX1555436 | 501A Epidermis | 2354 / 16449 (14.3%) | 9057 / 164490 (5.5%) | −324.0 | −324.0 | 2.60 |
| RUNX1 SRX2513054 | 293 Kidney | 4265 / 16449 (25.9%) | 16795 / 164490 (10.2%) | −324.0 | −324.0 | 2.54 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 2500 / 16449 (15.2%) | 9920 / 164490 (6.0%) | −324.0 | −324.0 | 2.52 |
| RUNX1 SRX2014504 | Jurkat Blood | 2997 / 16449 (18.2%) | 12106 / 164490 (7.4%) | −324.0 | −324.0 | 2.48 |
| CIC SRX13262055 | Astrocytes Neural | 3893 / 16449 (23.7%) | 15816 / 164490 (9.6%) | −324.0 | −324.0 | 2.46 |
| TRP47 SRX4548329 | THP-1 Blood | 3234 / 16449 (19.7%) | 13200 / 164490 (8.0%) | −324.0 | −324.0 | 2.45 |
| 5-mC SRX882965 | LNCAP Prostate | 2688 / 16449 (16.3%) | 11327 / 164490 (6.9%) | −324.0 | −324.0 | 2.37 |
| ATF3 SRX2207918 | CS1AN Epidermis | 2700 / 16449 (16.4%) | 11427 / 164490 (6.9%) | −324.0 | −324.0 | 2.36 |
| SUZ12 SRX10184494 | K-562 Blood | 2946 / 16449 (17.9%) | 13013 / 164490 (7.9%) | −324.0 | −324.0 | 2.26 |
| 5-mC SRX882968 | LNCAP Prostate | 3276 / 16449 (19.9%) | 14533 / 164490 (8.8%) | −324.0 | −324.0 | 2.25 |
| 5-mC SRX882970 | LNCAP Prostate | 3295 / 16449 (20.0%) | 14649 / 164490 (8.9%) | −324.0 | −324.0 | 2.25 |
| PBX4 SRX2731658 | PC-3 Prostate | 810 / 16449 (4.9%) | 25910 / 164490 (15.8%) | −324.0 | −324.0 | 0.31 |
| FOS SRX150478 | MCF 10A Breast | 532 / 16449 (3.2%) | 19823 / 164490 (12.1%) | −324.0 | −324.0 | 0.27 |
| FOS SRX150477 | MCF 10A Breast | 509 / 16449 (3.1%) | 19265 / 164490 (11.7%) | −324.0 | −324.0 | 0.26 |
| YAP1 SRX757325 | H2052 Lung | 497 / 16449 (3.0%) | 20069 / 164490 (12.2%) | −324.0 | −324.0 | 0.25 |
| YAP1 SRX757326 | H2052 Lung | 402 / 16449 (2.4%) | 17958 / 164490 (10.9%) | −324.0 | −324.0 | 0.22 |
| BRPF3 SRX796085 | RKO Digestive tract | 1333 / 16449 (8.1%) | 3383 / 164490 (2.1%) | −322.8 | −320.2 | 3.94 |
| CHD6 SRX17709201 | C4-2 Prostate | 1871 / 16449 (11.4%) | 6328 / 164490 (3.8%) | −319.4 | −316.8 | 2.96 |
| BCOR SRX10184493 | K-562 Blood | 2574 / 16449 (15.6%) | 10717 / 164490 (6.5%) | −319.0 | −316.4 | 2.40 |
| Epitope tags SRX15725652 | 293 Kidney | 2209 / 16449 (13.4%) | 8413 / 164490 (5.1%) | −316.4 | −313.8 | 2.63 |
| MEAF6 DRX300417 | 293 Kidney | 1851 / 16449 (11.3%) | 6264 / 164490 (3.8%) | −315.3 | −312.7 | 2.95 |
| KAT6A DRX366109 | 293 Kidney | 2444 / 16449 (14.9%) | 9938 / 164490 (6.0%) | −314.7 | −312.1 | 2.46 |
| Epitope tags SRX8030771 | 293 Kidney | 1980 / 16449 (12.0%) | 7051 / 164490 (4.3%) | −313.6 | −311.0 | 2.81 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 2275 / 16449 (13.8%) | 8891 / 164490 (5.4%) | −312.6 | −310.0 | 2.56 |
| CDK9 SRX20230573 | Ishikawa Uterus | 2557 / 16449 (15.5%) | 10775 / 164490 (6.6%) | −309.3 | −306.8 | 2.37 |
| KAT6A DRX366108 | 293 Kidney | 2069 / 16449 (12.6%) | 7657 / 164490 (4.7%) | −309.1 | −306.5 | 2.70 |
| TFEB SRX6743819 | iPS cells Pluripotent stem cell | 1790 / 16449 (10.9%) | 6047 / 164490 (3.7%) | −305.2 | −302.6 | 2.96 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 701 / 16449 (4.3%) | 870 / 164490 (0.5%) | −303.3 | −300.8 | 8.06 |
| TET2 SRX1427029 | 293 Kidney | 1595 / 16449 (9.7%) | 4992 / 164490 (3.0%) | −301.2 | −298.6 | 3.20 |
| Epitope tags DRX443510 | 293 Kidney | 1735 / 16449 (10.5%) | 5783 / 164490 (3.5%) | −301.1 | −298.5 | 3.00 |
| KAT6B DRX411443 | 293 Kidney | 2491 / 16449 (15.1%) | 10528 / 164490 (6.4%) | −299.0 | −296.5 | 2.37 |
| HEXIM1 SRX1177905 | HCT 116 Digestive tract | 2179 / 16449 (13.2%) | 8506 / 164490 (5.2%) | −298.9 | −296.4 | 2.56 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 693 / 16449 (4.2%) | 866 / 164490 (0.5%) | −298.5 | −296.0 | 8.00 |
| Epitope tags SRX2867680 | 293 Kidney | 2391 / 16449 (14.5%) | 9880 / 164490 (6.0%) | −298.4 | −295.9 | 2.42 |
| CTCF SRX12008351 | MCF 10A Breast | 3267 / 16449 (19.9%) | 15971 / 164490 (9.7%) | −297.2 | −294.6 | 2.05 |
| KMT2A SRX1293531 | MV-4-11 Blood | 2873 / 16449 (17.5%) | 13175 / 164490 (8.0%) | −296.6 | −294.1 | 2.18 |
| RORC SRX5359052 | HCC70 Breast | 1577 / 16449 (9.6%) | 4951 / 164490 (3.0%) | −296.4 | −293.8 | 3.19 |
| Epitope tags SRX15725650 | 293 Kidney | 1959 / 16449 (11.9%) | 7199 / 164490 (4.4%) | −295.1 | −292.6 | 2.72 |
| ZFX SRX7805370 | 293 Kidney | 1420 / 16449 (8.6%) | 4120 / 164490 (2.5%) | −294.5 | −291.9 | 3.45 |
| CREBBP SRX359409 | 293 Kidney | 1894 / 16449 (11.5%) | 6815 / 164490 (4.1%) | −294.4 | −291.9 | 2.78 |
| BCORL1 SRX10184496 | K-562 Blood | 2333 / 16449 (14.2%) | 9584 / 164490 (5.8%) | −293.7 | −291.2 | 2.43 |
| BCORL1 SRX10184498 | K-562 Blood | 2419 / 16449 (14.7%) | 10153 / 164490 (6.2%) | −293.3 | −290.8 | 2.38 |
| MYOCD SRX5598318 | A549 Lung | 2023 / 16449 (12.3%) | 7625 / 164490 (4.6%) | −292.9 | −290.4 | 2.65 |
| FOS SRX4192880 | MCF 10A Breast | 368 / 16449 (2.2%) | 15714 / 164490 (9.6%) | −292.0 | −289.6 | 0.23 |
| CDK9 SRX20230567 | Ishikawa Uterus | 2084 / 16449 (12.7%) | 8027 / 164490 (4.9%) | −291.6 | −289.1 | 2.60 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 703 / 16449 (4.3%) | 934 / 164490 (0.6%) | −291.3 | −288.8 | 7.53 |
| KAT6B DRX411444 | 293 Kidney | 2436 / 16449 (14.8%) | 10320 / 164490 (6.3%) | −290.3 | −287.9 | 2.36 |
| ING5 SRX286202 | RKO Digestive tract | 1554 / 16449 (9.4%) | 4903 / 164490 (3.0%) | −289.9 | −287.4 | 3.17 |
| BCORL1 SRX10184497 | K-562 Blood | 2348 / 16449 (14.3%) | 9755 / 164490 (5.9%) | −289.6 | −287.2 | 2.41 |
| LEO1 SRX1873456 | SEM Blood | 1705 / 16449 (10.4%) | 5814 / 164490 (3.5%) | −286.0 | −283.5 | 2.93 |
| CNOT3 SRX886388 | Colorectal carcinoma Digestive tract | 2246 / 16449 (13.7%) | 9158 / 164490 (5.6%) | −285.8 | −283.3 | 2.45 |
| ASCL1 SRX8949802 | Unclassified Unclassified | 2073 / 16449 (12.6%) | 8057 / 164490 (4.9%) | −285.4 | −282.9 | 2.57 |
| TET1 SRX10382426 | hESC H1 Pluripotent stem cell | 2737 / 16449 (16.6%) | 12462 / 164490 (7.6%) | −285.3 | −282.9 | 2.20 |
| CTCF SRX12008350 | MCF 10A Breast | 3301 / 16449 (20.1%) | 16530 / 164490 (10.0%) | −283.8 | −281.4 | 2.00 |
| JADE3 DRX300415 | 293 Kidney | 1771 / 16449 (10.8%) | 6236 / 164490 (3.8%) | −283.5 | −281.0 | 2.84 |
| ASCL1 SRX8949803 | Unclassified Unclassified | 2208 / 16449 (13.4%) | 8981 / 164490 (5.5%) | −281.7 | −279.2 | 2.46 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 1679 / 16449 (10.2%) | 5725 / 164490 (3.5%) | −281.4 | −278.9 | 2.93 |
| ZNF711 SRX7805363 | 293 Kidney | 1809 / 16449 (11.0%) | 6498 / 164490 (4.0%) | −281.2 | −278.8 | 2.78 |
| ESR1 SRX2897217 | Breast cancer cells Breast | 1222 / 16449 (7.4%) | 3239 / 164490 (2.0%) | −281.0 | −278.5 | 3.77 |
| KMT2A SRX2281247 | SEM Blood | 1916 / 16449 (11.6%) | 7158 / 164490 (4.4%) | −280.6 | −278.1 | 2.68 |
| CDK9 SRX20230570 | Ishikawa Uterus | 1985 / 16449 (12.1%) | 7627 / 164490 (4.6%) | −277.9 | −275.5 | 2.60 |
| RORC SRX5359053 | HCC70 Breast | 1494 / 16449 (9.1%) | 4731 / 164490 (2.9%) | −276.8 | −274.4 | 3.16 |
| Epitope tags SRX10549778 | K-562 Blood | 1328 / 16449 (8.1%) | 3830 / 164490 (2.3%) | −276.7 | −274.3 | 3.47 |
| HDAC1 SRX17989501 | PBMC Blood | 2344 / 16449 (14.3%) | 9966 / 164490 (6.1%) | −276.6 | −274.2 | 2.35 |
| ERG SRX063918 | MCF-7 Breast | 1756 / 16449 (10.7%) | 6261 / 164490 (3.8%) | −275.5 | −273.1 | 2.80 |
| HDAC1 SRX20517420 | Keratinocytes Epidermis | 1940 / 16449 (11.8%) | 7386 / 164490 (4.5%) | −275.4 | −273.0 | 2.63 |
| KDM5B SRX3285614 | C70R Breast | 1743 / 16449 (10.6%) | 6211 / 164490 (3.8%) | −273.7 | −271.3 | 2.81 |
| MEN1 SRX11712604 | K-562 Blood | 1649 / 16449 (10.0%) | 5664 / 164490 (3.4%) | −273.2 | −270.8 | 2.91 |
| PCGF1 SRX3256864 | hESC H1 Pluripotent stem cell | 2456 / 16449 (14.9%) | 10807 / 164490 (6.6%) | −271.7 | −269.3 | 2.27 |
| ZBTB26 SRX3322067 | 293 Kidney | 2186 / 16449 (13.3%) | 9058 / 164490 (5.5%) | −269.3 | −266.9 | 2.41 |
| Epitope tags SRX7276677 | 293 Kidney | 2932 / 16449 (17.8%) | 14203 / 164490 (8.6%) | −268.4 | −266.0 | 2.06 |
| TAF1 SRX11120885 | MCF-7 Breast | 1949 / 16449 (11.8%) | 7564 / 164490 (4.6%) | −267.9 | −265.5 | 2.58 |
| NABP2 SRX9523535 | HT-1080 Bone | 1608 / 16449 (9.8%) | 5512 / 164490 (3.4%) | −266.8 | −264.4 | 2.92 |
| RBFOX2 SRX3323050 | Hep G2 Liver | 1801 / 16449 (10.9%) | 6671 / 164490 (4.1%) | −266.3 | −263.9 | 2.70 |
| GRHL3 SRX2582162 | NHEK Epidermis | 1272 / 16449 (7.7%) | 3658 / 164490 (2.2%) | −265.6 | −263.2 | 3.48 |
| ZNF711 SRX7805362 | 293 Kidney | 1701 / 16449 (10.3%) | 6090 / 164490 (3.7%) | −264.7 | −262.4 | 2.79 |
| BMI1 SRX8726297 | Tumor Others | 1806 / 16449 (11.0%) | 6727 / 164490 (4.1%) | −264.7 | −262.4 | 2.68 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 1820 / 16449 (11.1%) | 6813 / 164490 (4.1%) | −264.6 | −262.3 | 2.67 |
| KDM2B SRX3256862 | hESC H1 Pluripotent stem cell | 2745 / 16449 (16.7%) | 12974 / 164490 (7.9%) | −263.8 | −261.5 | 2.12 |
| KDM5A SRX23740438 | SUM 149PT Breast | 1961 / 16449 (11.9%) | 7712 / 164490 (4.7%) | −263.5 | −261.1 | 2.54 |
| RBFOX2 SRX4708082 | K-562 Blood | 2610 / 16449 (15.9%) | 12035 / 164490 (7.3%) | −263.5 | −261.1 | 2.17 |
| G3BP1 SRX24196609 | KGN Gonad | 1875 / 16449 (11.4%) | 7173 / 164490 (4.4%) | −263.4 | −261.1 | 2.61 |
| STAT5A SRX9681372 | ARP-1 Blood | 1617 / 16449 (9.8%) | 5625 / 164490 (3.4%) | −262.5 | −260.1 | 2.87 |
| HDAC1 SRX17989500 | PBMC Blood | 1815 / 16449 (11.0%) | 6818 / 164490 (4.1%) | −262.4 | −260.0 | 2.66 |
| Epitope tags SRX10715360 | HCB1 Blood | 1348 / 16449 (8.2%) | 4107 / 164490 (2.5%) | −261.9 | −259.6 | 3.28 |
| Epitope tags SRX14024875 | Mesenchymal stem cells Others | 2041 / 16449 (12.4%) | 8250 / 164490 (5.0%) | −261.8 | −259.5 | 2.47 |
| MED1 SRX4937340 | HCT 116 Digestive tract | 1825 / 16449 (11.1%) | 6895 / 164490 (4.2%) | −261.4 | −259.0 | 2.65 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 935 / 16449 (5.7%) | 23833 / 164490 (14.5%) | −261.2 | −258.8 | 0.39 |
| Epitope tags SRX4192708 | MDA-MB-231 Breast | 1239 / 16449 (7.5%) | 3545 / 164490 (2.2%) | −260.1 | −257.8 | 3.50 |
| CDK9 SRX20230574 | Ishikawa Uterus | 1738 / 16449 (10.6%) | 6385 / 164490 (3.9%) | −260.0 | −257.7 | 2.72 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 1566 / 16449 (9.5%) | 5361 / 164490 (3.3%) | −259.8 | −257.5 | 2.92 |
| INTS3 SRX3640569 | HeLa Uterus | 1486 / 16449 (9.0%) | 4905 / 164490 (3.0%) | −259.6 | −257.3 | 3.03 |
| JUN SRX17561461 | LPS141 Adipocyte | 330 / 16449 (2.0%) | 14074 / 164490 (8.6%) | −259.5 | −257.2 | 0.23 |
| PGR SRX6068069 | Endometrium Uterus | 2071 / 16449 (12.6%) | 8487 / 164490 (5.2%) | −259.3 | −257.0 | 2.44 |
| GTF3C1 SRX4636577 | 293 Kidney | 1539 / 16449 (9.4%) | 5215 / 164490 (3.2%) | −259.1 | −256.8 | 2.95 |
| WAS SRX5371250 | GM11518 Blood | 1315 / 16449 (8.0%) | 3965 / 164490 (2.4%) | −258.8 | −256.5 | 3.32 |
| ING2 SRX286201 | RKO Digestive tract | 1619 / 16449 (9.8%) | 5691 / 164490 (3.5%) | −258.6 | −256.3 | 2.84 |
| CDK9 SRX20230572 | Ishikawa Uterus | 1963 / 16449 (11.9%) | 7807 / 164490 (4.7%) | −258.6 | −256.2 | 2.51 |
| SUZ12 SRX10184495 | K-562 Blood | 2261 / 16449 (13.7%) | 9763 / 164490 (5.9%) | −257.9 | −255.6 | 2.32 |
| KDM5A SRX23740431 | SUM 149PT Breast | 1697 / 16449 (10.3%) | 6175 / 164490 (3.8%) | −257.4 | −255.1 | 2.75 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 1274 / 16449 (7.7%) | 3781 / 164490 (2.3%) | −255.6 | −253.3 | 3.37 |
| ASCL1 SRX8949797 | Unclassified Unclassified | 2303 / 16449 (14.0%) | 10093 / 164490 (6.1%) | −255.4 | −253.1 | 2.28 |
| CTCF SRX10975999 | NALM-6 Blood | 3381 / 16449 (20.6%) | 17845 / 164490 (10.8%) | −254.9 | −252.6 | 1.89 |
| DOT1L SRX10606582 | GIST-T1 Digestive tract | 1911 / 16449 (11.6%) | 7543 / 164490 (4.6%) | −254.7 | −252.4 | 2.53 |
| ZFX SRX7805365 | 22Rv1 Prostate | 1570 / 16449 (9.5%) | 5481 / 164490 (3.3%) | −253.1 | −250.8 | 2.86 |
| BRD4 SRX2166889 | Retina Neural | 1617 / 16449 (9.8%) | 5758 / 164490 (3.5%) | −253.1 | −250.8 | 2.81 |
| ASCL1 SRX11245139 | DMS 53 Lung | 1688 / 16449 (10.3%) | 6188 / 164490 (3.8%) | −252.9 | −250.6 | 2.73 |
| KDM4C SRX424010 | KYSE-150 Digestive tract | 1431 / 16449 (8.7%) | 4686 / 164490 (2.8%) | −252.5 | −250.2 | 3.05 |
| TET1 SRX10382404 | hESC H1 Pluripotent stem cell | 2622 / 16449 (15.9%) | 12368 / 164490 (7.5%) | −251.9 | −249.6 | 2.12 |
| EP300 SRX24299742 | hESC H9 Pluripotent stem cell | 1940 / 16449 (11.8%) | 7790 / 164490 (4.7%) | −251.0 | −248.7 | 2.49 |
| KDM4A SRX5266973 | THP-1 Blood | 2077 / 16449 (12.6%) | 8696 / 164490 (5.3%) | −249.8 | −247.5 | 2.39 |
| KAT6A DRX411442 | 293 Kidney | 1914 / 16449 (11.6%) | 7648 / 164490 (4.6%) | −249.6 | −247.3 | 2.50 |
| TP53 SRX19538279 | Osteoblasts Bone | 432 / 16449 (2.6%) | 305 / 164490 (0.2%) | −248.9 | −246.6 | 14.16 |
| GATA3 SRX190194 | SK-N-SH Neural | 644 / 16449 (3.9%) | 18996 / 164490 (11.5%) | −248.2 | −245.9 | 0.34 |
| AFF1 SRX2281250 | SEM Blood | 1147 / 16449 (7.0%) | 3196 / 164490 (1.9%) | −248.1 | −245.9 | 3.59 |
| ERG SRX063917 | MCF-7 Breast | 1653 / 16449 (10.0%) | 6049 / 164490 (3.7%) | −248.1 | −245.8 | 2.73 |
| PHF6 SRX11508322 | G-401 Kidney | 1069 / 16449 (6.5%) | 2801 / 164490 (1.7%) | −248.1 | −245.8 | 3.82 |
| EP300 SRX24299743 | hESC H9 Pluripotent stem cell | 1865 / 16449 (11.3%) | 7363 / 164490 (4.5%) | −248.0 | −245.8 | 2.53 |
| Epitope tags SRX10549777 | K-562 Blood | 2625 / 16449 (16.0%) | 12475 / 164490 (7.6%) | −248.0 | −245.7 | 2.10 |
| FOS SRX150517 | MCF 10A Breast | 440 / 16449 (2.7%) | 15649 / 164490 (9.5%) | −247.4 | −245.2 | 0.28 |
| KMT2A SRX8151117 | VDH-15 Others | 2311 / 16449 (14.0%) | 10317 / 164490 (6.3%) | −246.9 | −244.6 | 2.24 |
| CREBBP SRX359408 | 293 Kidney | 1511 / 16449 (9.2%) | 5230 / 164490 (3.2%) | −246.3 | −244.1 | 2.89 |
| SREBF2 SRX5359049 | HCC70 Breast | 1370 / 16449 (8.3%) | 4432 / 164490 (2.7%) | −245.5 | −243.2 | 3.09 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 389 / 16449 (2.4%) | 218 / 164490 (0.1%) | −245.1 | −242.8 | 17.84 |
| BRD4 SRX2166886 | Retina Neural | 1969 / 16449 (12.0%) | 8086 / 164490 (4.9%) | −244.7 | −242.5 | 2.44 |
| HDAC1 SRX20517422 | Keratinocytes Epidermis | 1550 / 16449 (9.4%) | 5489 / 164490 (3.3%) | −244.3 | −242.0 | 2.82 |
| BCOR SRX3256873 | hESC H1 Pluripotent stem cell | 2511 / 16449 (15.3%) | 11775 / 164490 (7.2%) | −243.2 | −240.9 | 2.13 |
| TRIM24 SRX1041842 | LNCAP Prostate | 1323 / 16449 (8.0%) | 4212 / 164490 (2.6%) | −242.1 | −239.8 | 3.14 |
| KMT2A SRX8151120 | VDH-15 Others | 2281 / 16449 (13.9%) | 10213 / 164490 (6.2%) | −242.0 | −239.7 | 2.23 |
| TET2 SRX2513053 | Jurkat Blood | 2293 / 16449 (13.9%) | 10294 / 164490 (6.3%) | −242.0 | −239.7 | 2.23 |
| KDM5B SRX3285611 | MCF-7 Breast | 1438 / 16449 (8.7%) | 4865 / 164490 (3.0%) | −241.9 | −239.7 | 2.96 |
| Epitope tags SRX3657345 | 293 Kidney | 2554 / 16449 (15.5%) | 12126 / 164490 (7.4%) | −241.1 | −238.8 | 2.11 |
| Epitope tags SRX4892334 | 293 Kidney | 2558 / 16449 (15.6%) | 12154 / 164490 (7.4%) | −241.0 | −238.8 | 2.10 |
| FOS SRX150476 | MCF 10A Breast | 456 / 16449 (2.8%) | 15715 / 164490 (9.6%) | −240.8 | −238.6 | 0.29 |
| KMT2A SRX8151116 | VDH-15 Others | 1890 / 16449 (11.5%) | 7661 / 164490 (4.7%) | −239.9 | −237.7 | 2.47 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 530 / 16449 (3.2%) | 610 / 164490 (0.4%) | −239.5 | −237.3 | 8.69 |
| Epitope tags SRX25968097 | Brain organoids Neural | 1594 / 16449 (9.7%) | 5825 / 164490 (3.5%) | −239.3 | −237.1 | 2.74 |
| BCOR SRX3256874 | hESC H1 Pluripotent stem cell | 2220 / 16449 (13.5%) | 9859 / 164490 (6.0%) | −238.9 | −236.7 | 2.25 |
| RBFOX2 SRX3323051 | Hep G2 Liver | 1696 / 16449 (10.3%) | 6452 / 164490 (3.9%) | −238.9 | −236.7 | 2.63 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 975 / 16449 (5.9%) | 23621 / 164490 (14.4%) | −238.8 | −236.6 | 0.41 |
| MBD3 SRX1674506 | HeLa Uterus | 2787 / 16449 (16.9%) | 13853 / 164490 (8.4%) | −238.5 | −236.3 | 2.01 |
| STAT1 SRX23678708 | K-562 Blood | 1689 / 16449 (10.3%) | 6424 / 164490 (3.9%) | −238.1 | −235.9 | 2.63 |
| GTF3C1 SRX4636578 | 293 Kidney | 1499 / 16449 (9.1%) | 5282 / 164490 (3.2%) | −237.7 | −235.5 | 2.84 |
| CBFB SRX265218 | ME-1 Blood | 1648 / 16449 (10.0%) | 6182 / 164490 (3.8%) | −237.3 | −235.1 | 2.67 |
| BAHCC1 SRX8449942 | Jurkat Blood | 2744 / 16449 (16.7%) | 13578 / 164490 (8.3%) | −236.9 | −234.7 | 2.02 |
| RAG2 SRX1046558 | Thymus Blood | 2195 / 16449 (13.3%) | 9741 / 164490 (5.9%) | −236.3 | −234.1 | 2.25 |
| TET2 SRX2014505 | Jurkat Blood | 2805 / 16449 (17.1%) | 14038 / 164490 (8.5%) | −236.2 | −234.0 | 2.00 |
| RUNX1 SRX2963102 | PBMC Blood | 2136 / 16449 (13.0%) | 9350 / 164490 (5.7%) | −236.1 | −233.9 | 2.28 |
| NCAPH2 SRX2731517 | 293 Kidney | 1496 / 16449 (9.1%) | 5290 / 164490 (3.2%) | −235.8 | −233.6 | 2.83 |
| KMT2A SRX8151119 | VDH-15 Others | 2107 / 16449 (12.8%) | 9165 / 164490 (5.6%) | −235.5 | −233.3 | 2.30 |
| BCOR SRX10184500 | Acute myeloid leukemia Blood | 1803 / 16449 (11.0%) | 7206 / 164490 (4.4%) | −234.1 | −231.9 | 2.50 |
| KDM5B SRX3285563 | C49R Breast | 1518 / 16449 (9.2%) | 5456 / 164490 (3.3%) | −233.5 | −231.3 | 2.78 |
| TP53 SRX19538274 | U2OS Bone | 365 / 16449 (2.2%) | 196 / 164490 (0.1%) | −233.4 | −231.3 | 18.62 |
| NR1D1 SRX23813275 | C4-2B Prostate | 1909 / 16449 (11.6%) | 7898 / 164490 (4.8%) | −233.3 | −231.2 | 2.42 |
| Epitope tags SRX22482468 | 293 Kidney | 1490 / 16449 (9.1%) | 5302 / 164490 (3.2%) | −232.6 | −230.4 | 2.81 |
| KDM5B SRX3285604 | FULR Breast | 1579 / 16449 (9.6%) | 5837 / 164490 (3.5%) | −232.6 | −230.4 | 2.71 |
| KDM5A SRX23740430 | SUM 149PT Breast | 1834 / 16449 (11.1%) | 7474 / 164490 (4.5%) | −230.1 | −227.9 | 2.45 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 950 / 16449 (5.8%) | 22928 / 164490 (13.9%) | −229.6 | −227.4 | 0.41 |
| KDM5B SRX3285565 | C70R Breast | 1251 / 16449 (7.6%) | 3980 / 164490 (2.4%) | −228.7 | −226.5 | 3.14 |
| ERG SRX026657 | Acute promyelocytic leukemia Blood | 2053 / 16449 (12.5%) | 8948 / 164490 (5.4%) | −228.1 | −225.9 | 2.29 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 688 / 16449 (4.2%) | 18986 / 164490 (11.5%) | −227.6 | −225.4 | 0.36 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 1672 / 16449 (10.2%) | 6490 / 164490 (3.9%) | −227.6 | −225.4 | 2.58 |
| KMT2A SRX8151118 | VDH-15 Others | 2168 / 16449 (13.2%) | 9753 / 164490 (5.9%) | −226.6 | −224.5 | 2.22 |
| GFP SRX17864030 | 293 Kidney | 1632 / 16449 (9.9%) | 6260 / 164490 (3.8%) | −226.4 | −224.2 | 2.61 |
| TP53 SRX19538268 | U2OS Bone | 355 / 16449 (2.2%) | 193 / 164490 (0.1%) | −226.1 | −223.9 | 18.39 |
| CTCF SRX10976001 | NALM-6 Blood | 2683 / 16449 (16.3%) | 13403 / 164490 (8.1%) | −225.7 | −223.6 | 2.00 |
| EP300 SRX2671813 | Fibroblasts Others | 178 / 16449 (1.1%) | 10170 / 164490 (6.2%) | −225.6 | −223.5 | 0.18 |
| ZBTB26 SRX3322068 | 293 Kidney | 1967 / 16449 (12.0%) | 8434 / 164490 (5.1%) | −225.0 | −222.8 | 2.33 |
| TRIM25 SRX1660871 | Breast cancer cells Breast | 1694 / 16449 (10.3%) | 6677 / 164490 (4.1%) | −224.6 | −222.5 | 2.54 |
| GRHL3 SRX2582161 | NHEK Epidermis | 1042 / 16449 (6.3%) | 2908 / 164490 (1.8%) | −224.4 | −222.3 | 3.58 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 250 / 16449 (1.5%) | 11525 / 164490 (7.0%) | −223.3 | −221.1 | 0.22 |
| BRD4 SRX2166887 | Retina Neural | 1605 / 16449 (9.8%) | 6143 / 164490 (3.7%) | −223.2 | −221.0 | 2.61 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 986 / 16449 (6.0%) | 2641 / 164490 (1.6%) | −222.7 | −220.5 | 3.73 |
| JUNB SRX8488073 | SUM 229PE Breast | 529 / 16449 (3.2%) | 16330 / 164490 (9.9%) | −222.6 | −220.4 | 0.32 |
| TAF1 SRX11120886 | MCF-7 Breast | 1977 / 16449 (12.0%) | 8549 / 164490 (5.2%) | −222.5 | −220.3 | 2.31 |
| LARP7 SRX2198835 | HeLa Uterus | 2246 / 16449 (13.7%) | 10382 / 164490 (6.3%) | −222.1 | −220.0 | 2.16 |
| NCAPH2 SRX2731518 | 293 Kidney | 1430 / 16449 (8.7%) | 5105 / 164490 (3.1%) | −221.7 | −219.6 | 2.80 |
| Crotonyllysine SRX19488269 | GSC23 Neural | 1351 / 16449 (8.2%) | 4647 / 164490 (2.8%) | −221.3 | −219.1 | 2.91 |
| TP53 SRX19538276 | U2OS Bone | 351 / 16449 (2.1%) | 197 / 164490 (0.1%) | −221.0 | −218.9 | 17.82 |
| ESR1 SRX2901942 | Ishikawa Uterus | 1319 / 16449 (8.0%) | 4466 / 164490 (2.7%) | −221.0 | −218.8 | 2.95 |
| BRD4 SRX1272808 | COLO 741 Digestive tract | 1425 / 16449 (8.7%) | 5088 / 164490 (3.1%) | −220.9 | −218.7 | 2.80 |
| MCM3 SRX9107920 | hTERT RPE-1 Neural | 1051 / 16449 (6.4%) | 2994 / 164490 (1.8%) | −220.8 | −218.6 | 3.51 |
| KDM2B SRX3256876 | hESC H1 Pluripotent stem cell | 3003 / 16449 (18.3%) | 15916 / 164490 (9.7%) | −220.0 | −217.9 | 1.89 |
| Epitope tags SRX5770333 | HCT 116 Digestive tract | 1419 / 16449 (8.6%) | 5065 / 164490 (3.1%) | −220.0 | −217.9 | 2.80 |
| KDM5A SRX23740439 | SUM 149PT Breast | 1819 / 16449 (11.1%) | 7561 / 164490 (4.6%) | −219.8 | −217.7 | 2.41 |
| SMARCA4 SRX9562887 | RH-4 Muscle | 1639 / 16449 (10.0%) | 6413 / 164490 (3.9%) | −219.6 | −217.5 | 2.56 |
| MethylCap SRX014767 | NB-4 Blood | 1852 / 16449 (11.3%) | 7794 / 164490 (4.7%) | −218.8 | −216.7 | 2.38 |
| KDM5B SRX3285594 | MCF-7 Breast | 1536 / 16449 (9.3%) | 5795 / 164490 (3.5%) | −218.4 | −216.3 | 2.65 |
| CTCF SRX10976007 | NALM-6 Blood | 2705 / 16449 (16.4%) | 13757 / 164490 (8.4%) | −217.9 | −215.8 | 1.97 |
| FOS SRX4192879 | MCF 10A Breast | 301 / 16449 (1.8%) | 12310 / 164490 (7.5%) | −217.7 | −215.6 | 0.24 |
| BRD4 SRX736204 | 90-8TL Neural | 992 / 16449 (6.0%) | 2725 / 164490 (1.7%) | −217.5 | −215.4 | 3.64 |
| STAT1 SRX23678707 | K-562 Blood | 1545 / 16449 (9.4%) | 5879 / 164490 (3.6%) | −216.6 | −214.5 | 2.63 |
| PBRM1 SRX25399433 | Melanoma Epidermis | 1299 / 16449 (7.9%) | 4410 / 164490 (2.7%) | −216.6 | −214.5 | 2.95 |
| KMT2A SRX8151121 | VDH-15 Others | 2261 / 16449 (13.7%) | 10616 / 164490 (6.5%) | −216.2 | −214.1 | 2.13 |
| SS18L1 SRX10881821 | G-401 Kidney | 2106 / 16449 (12.8%) | 9549 / 164490 (5.8%) | −216.0 | −213.9 | 2.21 |
| SP1 SRX113706 | HCT 116 Digestive tract | 1954 / 16449 (11.9%) | 8524 / 164490 (5.2%) | −216.0 | −213.9 | 2.29 |
| CDT1 SRX10644243 | HCT 116 Digestive tract | 1741 / 16449 (10.6%) | 7128 / 164490 (4.3%) | −215.7 | −213.6 | 2.44 |
| JUNB SRX10119386 | MCF 10A Breast | 216 / 16449 (1.3%) | 10643 / 164490 (6.5%) | −215.4 | −213.3 | 0.20 |
| CDK9 SRX20230568 | Ishikawa Uterus | 2440 / 16449 (14.8%) | 11905 / 164490 (7.2%) | −215.1 | −213.0 | 2.05 |
| RBFOX2 SRX3322781 | K-562 Blood | 2126 / 16449 (12.9%) | 9711 / 164490 (5.9%) | −214.9 | −212.8 | 2.19 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 754 / 16449 (4.6%) | 1614 / 164490 (1.0%) | −214.5 | −212.4 | 4.67 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 901 / 16449 (5.5%) | 2300 / 164490 (1.4%) | −214.5 | −212.4 | 3.92 |
| TP53 SRX19538275 | U2OS Bone | 339 / 16449 (2.1%) | 188 / 164490 (0.1%) | −214.4 | −212.3 | 18.03 |
| KDM2B SRX3256875 | hESC H1 Pluripotent stem cell | 3022 / 16449 (18.4%) | 16213 / 164490 (9.9%) | −214.3 | −212.2 | 1.86 |
| AR SRX10820653 | LNCAP Prostate | 335 / 16449 (2.0%) | 182 / 164490 (0.1%) | −213.4 | −211.3 | 18.41 |
| NELFA SRX10333914 | DLD-1 Digestive tract | 1432 / 16449 (8.7%) | 5244 / 164490 (3.2%) | −213.1 | −211.0 | 2.73 |
| DOT1L SRX10606583 | GIST-T1 Digestive tract | 1355 / 16449 (8.2%) | 4786 / 164490 (2.9%) | −213.1 | −211.0 | 2.83 |
| BRD4 SRX23813262 | C4-2B Prostate | 1678 / 16449 (10.2%) | 6776 / 164490 (4.1%) | −212.9 | −210.8 | 2.48 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 231 / 16449 (1.4%) | 10851 / 164490 (6.6%) | −212.5 | −210.5 | 0.21 |
| TFAP2A SRX20744801 | GP5d Digestive tract | 1097 / 16449 (6.7%) | 3344 / 164490 (2.0%) | −211.6 | −209.5 | 3.28 |
| TP53 SRX19538273 | U2OS Bone | 325 / 16449 (2.0%) | 166 / 164490 (0.1%) | −211.4 | −209.4 | 19.58 |
| SETD1A SRX23734379 | MOLM-13 Blood | 1338 / 16449 (8.1%) | 4715 / 164490 (2.9%) | −211.0 | −208.9 | 2.84 |
| BCOR SRX10184504 | OCI-AML3 Blood | 1732 / 16449 (10.5%) | 7161 / 164490 (4.4%) | −210.8 | −208.7 | 2.42 |
| JUNB SRX4192882 | MCF 10A Breast | 186 / 16449 (1.1%) | 9908 / 164490 (6.0%) | −210.5 | −208.4 | 0.19 |
| KDM2B SRX1873447 | SEM Blood | 2526 / 16449 (15.4%) | 12633 / 164490 (7.7%) | −210.5 | −208.4 | 2.00 |
| KMT2B DRX059614 | HB1119 Blood | 979 / 16449 (6.0%) | 2741 / 164490 (1.7%) | −209.7 | −207.6 | 3.57 |
| ZFX SRX3322295 | HCT 116 Digestive tract | 1435 / 16449 (8.7%) | 5320 / 164490 (3.2%) | −209.3 | −207.2 | 2.70 |
| GFP SRX17864029 | 293 Kidney | 1313 / 16449 (8.0%) | 4597 / 164490 (2.8%) | −209.1 | −207.0 | 2.86 |
| Epitope tags SRX2255894 | 293 Kidney | 1449 / 16449 (8.8%) | 5416 / 164490 (3.3%) | −208.7 | −206.6 | 2.68 |
| MYC SRX13134693 | 293 Kidney | 1409 / 16449 (8.6%) | 5191 / 164490 (3.2%) | −207.5 | −205.5 | 2.71 |
| Epitope tags SRX8109065 | Gastric cancer cells Digestive tract | 1761 / 16449 (10.7%) | 7412 / 164490 (4.5%) | −207.3 | −205.3 | 2.38 |
| TP53 SRX19538267 | U2OS Bone | 321 / 16449 (2.0%) | 168 / 164490 (0.1%) | −207.1 | −205.1 | 19.11 |
| BAHCC1 SRX8449940 | Jurkat Blood | 2390 / 16449 (14.5%) | 11748 / 164490 (7.1%) | −206.6 | −204.6 | 2.03 |
| SS18 SRX3468047 | Fibroblasts Others | 777 / 16449 (4.7%) | 19584 / 164490 (11.9%) | −206.6 | −204.5 | 0.40 |
| Epitope tags SRX14024876 | Mesenchymal stem cells Others | 2326 / 16449 (14.1%) | 11296 / 164490 (6.9%) | −206.3 | −204.3 | 2.06 |
| KLF4 SRX12144701 | T/C28a2 Bone | 2814 / 16449 (17.1%) | 14865 / 164490 (9.0%) | −206.3 | −204.2 | 1.89 |
| ASCL1 SRX11245136 | DMS 53 Lung | 1845 / 16449 (11.2%) | 7993 / 164490 (4.9%) | −205.8 | −203.7 | 2.31 |
| WAS SRX5371248 | Lymphoblastoid cell line Blood | 1033 / 16449 (6.3%) | 3068 / 164490 (1.9%) | −205.8 | −203.7 | 3.37 |
| CRTC2 SRX5576990 | A549 Lung | 1958 / 16449 (11.9%) | 8759 / 164490 (5.3%) | −205.4 | −203.3 | 2.24 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 504 / 16449 (3.1%) | 687 / 164490 (0.4%) | −204.8 | −202.7 | 7.34 |
| TP53 SRX396254 | Fibroblasts Others | 936 / 16449 (5.7%) | 2573 / 164490 (1.6%) | −204.8 | −202.7 | 3.64 |
| ZFX SRX3091912 | HCT 116 Digestive tract | 1419 / 16449 (8.6%) | 5296 / 164490 (3.2%) | −204.7 | −202.7 | 2.68 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 268 / 16449 (1.6%) | 11315 / 164490 (6.9%) | −204.7 | −202.6 | 0.24 |
| GFP SRX1514953 | 293 Kidney | 2533 / 16449 (15.4%) | 12835 / 164490 (7.8%) | −204.5 | −202.4 | 1.97 |
| FOSL2 SRX190296 | SK-N-SH Neural | 378 / 16449 (2.3%) | 13246 / 164490 (8.1%) | −204.3 | −202.3 | 0.29 |
| JUND SRX190357 | SK-N-SH Neural | 354 / 16449 (2.2%) | 12829 / 164490 (7.8%) | −204.2 | −202.1 | 0.28 |
| SMARCA4 SRX4193368 | 22Rv1 Prostate | 1226 / 16449 (7.5%) | 4163 / 164490 (2.5%) | −204.0 | −201.9 | 2.94 |
| BRD4 SRX8272937 | BLaER1 Blood | 1405 / 16449 (8.5%) | 5225 / 164490 (3.2%) | −203.8 | −201.8 | 2.69 |
| RBFOX2 SRX3322782 | K-562 Blood | 1982 / 16449 (12.0%) | 8974 / 164490 (5.5%) | −203.0 | −201.0 | 2.21 |
| NIPBL SRX7805899 | Dermal fibroblast Epidermis | 1320 / 16449 (8.0%) | 4732 / 164490 (2.9%) | −202.6 | −200.6 | 2.79 |
| TP53 SRX19538280 | Osteoblasts Bone | 343 / 16449 (2.1%) | 228 / 164490 (0.1%) | −202.5 | −200.5 | 15.04 |
| KAT7 DRX234808 | 293 Kidney | 849 / 16449 (5.2%) | 2164 / 164490 (1.3%) | −202.2 | −200.2 | 3.92 |
| JADE3 DRX234809 | 293 Kidney | 1095 / 16449 (6.7%) | 3449 / 164490 (2.1%) | −202.1 | −200.0 | 3.17 |
| KDM4A SRX116463 | hESC H1 Pluripotent stem cell | 1804 / 16449 (11.0%) | 7799 / 164490 (4.7%) | −201.8 | −199.8 | 2.31 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 803 / 16449 (4.9%) | 1951 / 164490 (1.2%) | −201.3 | −199.3 | 4.12 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 662 / 16449 (4.0%) | 1317 / 164490 (0.8%) | −201.2 | −199.2 | 5.03 |
| HDAC1 SRX20419390 | Keratinocytes Epidermis | 1283 / 16449 (7.8%) | 4535 / 164490 (2.8%) | −201.1 | −199.1 | 2.83 |
| Epitope tags SRX9034608 | VCaP Prostate | 2113 / 16449 (12.8%) | 9918 / 164490 (6.0%) | −201.0 | −198.9 | 2.13 |
| HDAC2 SRX16386913 | 293 Kidney | 873 / 16449 (5.3%) | 2297 / 164490 (1.4%) | −200.7 | −198.7 | 3.80 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 413 / 16449 (2.5%) | 13723 / 164490 (8.3%) | −200.7 | −198.7 | 0.30 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 914 / 16449 (5.6%) | 21341 / 164490 (13.0%) | −200.6 | −198.6 | 0.43 |
| JUN SRX4192884 | MCF 10A Breast | 219 / 16449 (1.3%) | 10266 / 164490 (6.2%) | −200.3 | −198.3 | 0.21 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 710 / 16449 (4.3%) | 18345 / 164490 (11.2%) | −199.8 | −197.8 | 0.39 |
| EP300 SRX359405 | 293 Kidney | 1194 / 16449 (7.3%) | 4039 / 164490 (2.5%) | −199.6 | −197.6 | 2.96 |
| KDM1A SRX16386914 | 293 Kidney | 1055 / 16449 (6.4%) | 3269 / 164490 (2.0%) | −198.9 | −196.8 | 3.23 |
| TCF12 SRX190356 | SK-N-SH Neural | 871 / 16449 (5.3%) | 20650 / 164490 (12.6%) | −198.4 | −196.4 | 0.42 |
| HNRNPC SRX4708020 | Hep G2 Liver | 1147 / 16449 (7.0%) | 3788 / 164490 (2.3%) | −198.3 | −196.3 | 3.03 |
| ZFX SRX3091909 | C4-2 Prostate | 1266 / 16449 (7.7%) | 4479 / 164490 (2.7%) | −198.1 | −196.1 | 2.83 |
| BCOR SRX10184505 | KG-1 Blood | 1038 / 16449 (6.3%) | 3188 / 164490 (1.9%) | −197.9 | −195.9 | 3.26 |
| Epitope tags SRX7276675 | 293 Kidney | 2470 / 16449 (15.0%) | 12542 / 164490 (7.6%) | −197.8 | −195.8 | 1.97 |
| KMT2B DRX059615 | HB1119 Blood | 961 / 16449 (5.8%) | 2783 / 164490 (1.7%) | −197.3 | −195.3 | 3.45 |
| JUN SRX883584 | MDA-MB-231 Breast | 475 / 16449 (2.9%) | 14626 / 164490 (8.9%) | −197.3 | −195.3 | 0.32 |
| SMARCA2 SRX8119677 | MeT-5A Others | 503 / 16449 (3.1%) | 15076 / 164490 (9.2%) | −197.3 | −195.3 | 0.33 |
| ZFX SRX3321903 | C4-2 Prostate | 1290 / 16449 (7.8%) | 4635 / 164490 (2.8%) | −197.1 | −195.1 | 2.78 |
| CTCF SRX10976000 | NALM-6 Blood | 2933 / 16449 (17.8%) | 16026 / 164490 (9.7%) | −196.8 | −194.8 | 1.83 |
| ZFY SRX7805367 | 22Rv1 Prostate | 1010 / 16449 (6.1%) | 3055 / 164490 (1.9%) | −196.3 | −194.3 | 3.31 |
| KDM4A SRX186675 | hESC H1 Pluripotent stem cell | 1791 / 16449 (10.9%) | 7823 / 164490 (4.8%) | −196.2 | −194.2 | 2.29 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 614 / 16449 (3.7%) | 16746 / 164490 (10.2%) | −195.5 | −193.5 | 0.37 |
| Epitope tags SRX9034613 | VCaP Prostate | 2322 / 16449 (14.1%) | 11526 / 164490 (7.0%) | −195.5 | −193.5 | 2.01 |
| Epitope tags SRX9034609 | VCaP Prostate | 2273 / 16449 (13.8%) | 11179 / 164490 (6.8%) | −195.3 | −193.3 | 2.03 |
| ELF1 SRX265229 | ME-1 Blood | 1050 / 16449 (6.4%) | 3294 / 164490 (2.0%) | −194.6 | −192.6 | 3.19 |
| EP300 ERX626821 | U-937 Blood | 1281 / 16449 (7.8%) | 4632 / 164490 (2.8%) | −193.6 | −191.6 | 2.77 |
| JUN SRX6582172 | Fibroblasts Others | 396 / 16449 (2.4%) | 13206 / 164490 (8.0%) | −193.6 | −191.6 | 0.30 |
| Epitope tags SRX9034615 | VCaP Prostate | 2248 / 16449 (13.7%) | 11050 / 164490 (6.7%) | −193.2 | −191.2 | 2.03 |
| JUN SRX6582171 | GM07492 Others | 607 / 16449 (3.7%) | 16556 / 164490 (10.1%) | −193.1 | −191.1 | 0.37 |
| Epitope tags SRX9034614 | VCaP Prostate | 2265 / 16449 (13.8%) | 11185 / 164490 (6.8%) | −192.6 | −190.6 | 2.03 |
| GFP SRX20436833 | DLD-1 Digestive tract | 1538 / 16449 (9.4%) | 6238 / 164490 (3.8%) | −192.5 | −190.5 | 2.47 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 614 / 16449 (3.7%) | 16638 / 164490 (10.1%) | −192.4 | −190.4 | 0.37 |
| SAP30 SRX17989897 | MDA-MB-231 Breast | 1972 / 16449 (12.0%) | 9143 / 164490 (5.6%) | −191.8 | −189.8 | 2.16 |
| SUPT5H SRX11555382 | DLD-1 Digestive tract | 1735 / 16449 (10.5%) | 7541 / 164490 (4.6%) | −191.6 | −189.6 | 2.30 |
| JUNB SRX8488074 | SUM 229PE Breast | 402 / 16449 (2.4%) | 13229 / 164490 (8.0%) | −191.1 | −189.1 | 0.30 |
| Epitope tags SRX9034612 | VCaP Prostate | 2573 / 16449 (15.6%) | 13469 / 164490 (8.2%) | −191.1 | −189.1 | 1.91 |
| PSIP1 SRX1293534 | MV-4-11 Blood | 962 / 16449 (5.8%) | 2861 / 164490 (1.7%) | −191.0 | −189.0 | 3.36 |
| ZNF768 SRX10478010 | Hep G2 Liver | 3039 / 16449 (18.5%) | 17029 / 164490 (10.4%) | −190.3 | −188.3 | 1.78 |
| RBM22 SRX4708083 | K-562 Blood | 991 / 16449 (6.0%) | 3026 / 164490 (1.8%) | −190.2 | −188.2 | 3.27 |
| CTCF SRX12008354 | MCF 10A Breast | 3941 / 16449 (24.0%) | 24232 / 164490 (14.7%) | −190.1 | −188.1 | 1.63 |
| Epitope tags SRX15683099 | HS-SY-II Lung | 2022 / 16449 (12.3%) | 9530 / 164490 (5.8%) | −190.0 | −188.0 | 2.12 |
| CTCF SRX10976008 | NALM-6 Blood | 2555 / 16449 (15.5%) | 13367 / 164490 (8.1%) | −190.0 | −188.0 | 1.91 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 680 / 16449 (4.1%) | 17543 / 164490 (10.7%) | −189.8 | −187.8 | 0.39 |
| CHD1 SRX116454 | hESC H1 Pluripotent stem cell | 880 / 16449 (5.3%) | 2449 / 164490 (1.5%) | −189.4 | −187.5 | 3.59 |
| Epitope tags SRX12024485 | Polycystic kidney Kidney | 2651 / 16449 (16.1%) | 14106 / 164490 (8.6%) | −189.2 | −187.2 | 1.88 |
| ZNF711 SRX7805369 | 22Rv1 Prostate | 847 / 16449 (5.1%) | 2288 / 164490 (1.4%) | −188.8 | −186.8 | 3.70 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 810 / 16449 (4.9%) | 2104 / 164490 (1.3%) | −188.7 | −186.8 | 3.85 |
| TP53 SRX19538281 | Osteoblasts Bone | 367 / 16449 (2.2%) | 332 / 164490 (0.2%) | −188.7 | −186.8 | 11.05 |
| KDM5B SRX3285610 | MCF-7 Breast | 1333 / 16449 (8.1%) | 5024 / 164490 (3.1%) | −188.7 | −186.7 | 2.65 |
| LEO1 SRX15147190 | DLD-1 Digestive tract | 931 / 16449 (5.7%) | 2723 / 164490 (1.7%) | −188.7 | −186.7 | 3.42 |
| EP300 ERX626811 | U-937 Blood | 1273 / 16449 (7.7%) | 4672 / 164490 (2.8%) | −188.0 | −186.0 | 2.72 |
| IRF3 SRX11453858 | Hep G2 Liver | 260 / 16449 (1.6%) | 94 / 164490 (0.1%) | −187.7 | −185.8 | 27.66 |
| ESR1 SRX2897216 | Breast cancer cells Breast | 718 / 16449 (4.4%) | 1674 / 164490 (1.0%) | −187.6 | −185.7 | 4.29 |
| Epitope tags SRX9034611 | VCaP Prostate | 2163 / 16449 (13.1%) | 10576 / 164490 (6.4%) | −187.6 | −185.6 | 2.05 |
| BRD2 SRX10760645 | MM.1S Blood | 1920 / 16449 (11.7%) | 8883 / 164490 (5.4%) | −187.3 | −185.3 | 2.16 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 557 / 16449 (3.4%) | 15579 / 164490 (9.5%) | −187.2 | −185.2 | 0.36 |
| ETS1 SRX5705796 | hESC derived cardiac cells Pluripotent stem cell | 1537 / 16449 (9.3%) | 6328 / 164490 (3.8%) | −187.1 | −185.2 | 2.43 |
| CDYL SRX25968095 | Brain organoids Neural | 1405 / 16449 (8.5%) | 5493 / 164490 (3.3%) | −187.1 | −185.2 | 2.56 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 201 / 16449 (1.2%) | 9525 / 164490 (5.8%) | −186.9 | −184.9 | 0.21 |
| JUN SRX7277180 | GM07492 Others | 226 / 16449 (1.4%) | 10002 / 164490 (6.1%) | −186.8 | −184.8 | 0.23 |
| Epitope tags SRX9034607 | VCaP Prostate | 2402 / 16449 (14.6%) | 12326 / 164490 (7.5%) | −186.7 | −184.8 | 1.95 |
| JUNB SRX8488088 | SUM 229PE Breast | 630 / 16449 (3.8%) | 16677 / 164490 (10.1%) | −186.6 | −184.7 | 0.38 |
| CDK9 SRX20230571 | Ishikawa Uterus | 2319 / 16449 (14.1%) | 11722 / 164490 (7.1%) | −186.5 | −184.6 | 1.98 |
| Epitope tags SRX16386911 | 293 Kidney | 1066 / 16449 (6.5%) | 3489 / 164490 (2.1%) | −186.3 | −184.3 | 3.06 |
| BRD2 SRX8090652 | Synoviocytes Others | 1245 / 16449 (7.6%) | 4534 / 164490 (2.8%) | −186.0 | −184.0 | 2.75 |
| JUNB SRX10119384 | MCF 10A Breast | 155 / 16449 (0.9%) | 8584 / 164490 (5.2%) | −186.0 | −184.0 | 0.18 |
| CTCF SRX10976010 | 697 Blood | 2008 / 16449 (12.2%) | 9525 / 164490 (5.8%) | −185.8 | −183.9 | 2.11 |
| AR SRX10820651 | LNCAP Prostate | 348 / 16449 (2.1%) | 295 / 164490 (0.2%) | −184.7 | −182.7 | 11.80 |
| Epitope tags SRX667413 | MCF-7 Breast | 1968 / 16449 (12.0%) | 9276 / 164490 (5.6%) | −184.4 | −182.5 | 2.12 |
| JUNB SRX10119383 | MCF 10A Breast | 188 / 16449 (1.1%) | 9199 / 164490 (5.6%) | −184.3 | −182.3 | 0.20 |
| CTCF SRX10976009 | 697 Blood | 2329 / 16449 (14.2%) | 11862 / 164490 (7.2%) | −184.0 | −182.1 | 1.96 |
| ESR1 SRX371478 | MCF-7 Breast | 424 / 16449 (2.6%) | 13356 / 164490 (8.1%) | −184.0 | −182.0 | 0.32 |
| WDR5 SRX689366 | 293 Kidney | 1875 / 16449 (11.4%) | 8644 / 164490 (5.3%) | −183.9 | −182.0 | 2.17 |
| ZFX SRX3091916 | 293 Kidney | 1661 / 16449 (10.1%) | 7206 / 164490 (4.4%) | −183.5 | −181.6 | 2.31 |
| ZFX SRX7805360 | 293 Kidney | 1661 / 16449 (10.1%) | 7206 / 164490 (4.4%) | −183.5 | −181.6 | 2.31 |
| ZFX SRX3322014 | 293 Kidney | 1308 / 16449 (8.0%) | 4954 / 164490 (3.0%) | −183.5 | −181.6 | 2.64 |
| FOXA1 SRX4815198 | MCF-7 Breast | 1122 / 16449 (6.8%) | 23554 / 164490 (14.3%) | −183.4 | −181.5 | 0.48 |
| SS18L1 SRX10881824 | G-401 Kidney | 2308 / 16449 (14.0%) | 11725 / 164490 (7.1%) | −183.4 | −181.4 | 1.97 |
| FOXA1 SRX176863 | MCF-7 Breast | 396 / 16449 (2.4%) | 12855 / 164490 (7.8%) | −182.8 | −180.8 | 0.31 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 243 / 16449 (1.5%) | 10179 / 164490 (6.2%) | −182.1 | −180.2 | 0.24 |
| KDM5B SRX3285595 | MCF-7 Breast | 1273 / 16449 (7.7%) | 4763 / 164490 (2.9%) | −181.9 | −180.0 | 2.67 |
| ESR1 SRX2897214 | Breast cancer cells Breast | 536 / 16449 (3.3%) | 938 / 164490 (0.6%) | −181.4 | −179.4 | 5.71 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 539 / 16449 (3.3%) | 956 / 164490 (0.6%) | −180.4 | −178.5 | 5.64 |
| KMT2A SRX4931251 | 293 Kidney | 997 / 16449 (6.1%) | 3180 / 164490 (1.9%) | −180.4 | −178.4 | 3.14 |
| KDM5B SRX3285586 | TAMR Breast | 1104 / 16449 (6.7%) | 3797 / 164490 (2.3%) | −179.5 | −177.6 | 2.91 |
| LARP7 SRX1177904 | HCT 116 Digestive tract | 1171 / 16449 (7.1%) | 4191 / 164490 (2.5%) | −179.5 | −177.5 | 2.79 |
| KLF4 SRX12144702 | T/C28a2 Bone | 2472 / 16449 (15.0%) | 13040 / 164490 (7.9%) | −179.1 | −177.2 | 1.90 |
| FOS SRX070879 | HUVEC Cardiovascular | 328 / 16449 (2.0%) | 11590 / 164490 (7.0%) | −179.0 | −177.1 | 0.28 |
| PBRM1 SRX9562888 | RH-4 Muscle | 937 / 16449 (5.7%) | 2869 / 164490 (1.7%) | −178.9 | −177.0 | 3.27 |
| UBTF SRX10478330 | Hep G2 Liver | 1909 / 16449 (11.6%) | 8990 / 164490 (5.5%) | −178.8 | −176.9 | 2.12 |
| KDM5B SRX3285605 | FULR Breast | 939 / 16449 (5.7%) | 2882 / 164490 (1.8%) | −178.7 | −176.8 | 3.26 |
| FOXA1 SRX176862 | MCF-7 Breast | 442 / 16449 (2.7%) | 13468 / 164490 (8.2%) | −178.5 | −176.6 | 0.33 |
| BRD4 SRX23813260 | C4-2B Prostate | 1240 / 16449 (7.5%) | 4621 / 164490 (2.8%) | −178.3 | −176.3 | 2.68 |
| TP53 SRX19538269 | U2OS Bone | 399 / 16449 (2.4%) | 468 / 164490 (0.3%) | −178.1 | −176.2 | 8.53 |
| SUPT5H SRX11555383 | DLD-1 Digestive tract | 1618 / 16449 (9.8%) | 7029 / 164490 (4.3%) | −178.0 | −176.1 | 2.30 |
| CHD6 SRX17709202 | C4-2 Prostate | 1146 / 16449 (7.0%) | 4064 / 164490 (2.5%) | −178.0 | −176.0 | 2.82 |
| AFF1 SRX10484575 | RS4-11 Blood | 1491 / 16449 (9.1%) | 6204 / 164490 (3.8%) | −177.8 | −175.9 | 2.40 |
| ZFX SRX3322015 | 293 Kidney | 1673 / 16449 (10.2%) | 7408 / 164490 (4.5%) | −177.5 | −175.6 | 2.26 |
| GFP SRX5486428 | HCT 116 Digestive tract | 1514 / 16449 (9.2%) | 6358 / 164490 (3.9%) | −177.4 | −175.5 | 2.38 |
| SMARCA4 SRX5212357 | Mel270 Others | 473 / 16449 (2.9%) | 13925 / 164490 (8.5%) | −177.4 | −175.5 | 0.34 |
| JUND SRX699738 | HCASMC Cardiovascular | 452 / 16449 (2.7%) | 13581 / 164490 (8.3%) | −177.2 | −175.3 | 0.33 |
| GATA3 SRX176864 | MCF-7 Breast | 227 / 16449 (1.4%) | 9724 / 164490 (5.9%) | −176.9 | −175.0 | 0.23 |
| SETD1A SRX23734380 | MOLM-13 Blood | 1082 / 16449 (6.6%) | 3706 / 164490 (2.3%) | −176.8 | −174.9 | 2.92 |
| Epitope tags SRX9034610 | VCaP Prostate | 2473 / 16449 (15.0%) | 13114 / 164490 (8.0%) | −176.8 | −174.9 | 1.89 |
| MEN1 SRX14030481 | MV-4-11 Blood | 932 / 16449 (5.7%) | 2881 / 164490 (1.8%) | −175.7 | −173.8 | 3.23 |
| BRD4 SRX3591434 | B-CLL cells Blood | 1533 / 16449 (9.3%) | 6516 / 164490 (4.0%) | −175.7 | −173.8 | 2.35 |
| ZFX SRX3091917 | 293 Kidney | 1273 / 16449 (7.7%) | 4872 / 164490 (3.0%) | −175.2 | −173.3 | 2.61 |
| ZFX SRX7805361 | 293 Kidney | 1273 / 16449 (7.7%) | 4872 / 164490 (3.0%) | −175.2 | −173.3 | 2.61 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 426 / 16449 (2.6%) | 13097 / 164490 (8.0%) | −175.2 | −173.3 | 0.33 |
| DMC1 SRX663450 | Testis Gonad | 636 / 16449 (3.9%) | 1406 / 164490 (0.9%) | −175.1 | −173.2 | 4.52 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 443 / 16449 (2.7%) | 13363 / 164490 (8.1%) | −175.0 | −173.1 | 0.33 |
| HDAC1 SRX18517814 | Keratinocytes Epidermis | 1025 / 16449 (6.2%) | 3411 / 164490 (2.1%) | −174.7 | −172.8 | 3.00 |
| EP300 SRX150579 | HeLa Uterus | 193 / 16449 (1.2%) | 9014 / 164490 (5.5%) | −174.6 | −172.7 | 0.21 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 436 / 16449 (2.7%) | 13238 / 164490 (8.0%) | −174.5 | −172.6 | 0.33 |
| TAF3 SRX217738 | HCT 116 Digestive tract | 1270 / 16449 (7.7%) | 4870 / 164490 (3.0%) | −174.1 | −172.2 | 2.61 |
| BRD4 SRX2166888 | Retina Neural | 1342 / 16449 (8.2%) | 5322 / 164490 (3.2%) | −174.0 | −172.1 | 2.52 |
| MEN1 SRX14030471 | MV-4-11 Blood | 1016 / 16449 (6.2%) | 3374 / 164490 (2.1%) | −173.6 | −171.7 | 3.01 |
| ERG SRX063920 | K-562 Blood | 918 / 16449 (5.6%) | 2831 / 164490 (1.7%) | −173.6 | −171.7 | 3.24 |
| CTCF SRX10976002 | NALM-6 Blood | 2864 / 16449 (17.4%) | 16182 / 164490 (9.8%) | −173.4 | −171.5 | 1.77 |
| KMT2A SRX4931241 | 293 Kidney | 1217 / 16449 (7.4%) | 4559 / 164490 (2.8%) | −173.4 | −171.5 | 2.67 |
| CTCFL SRX1091814 | K-562 Blood | 1536 / 16449 (9.3%) | 6584 / 164490 (4.0%) | −173.2 | −171.3 | 2.33 |
| SMARCA4 SRX5212366 | Mel270 Others | 445 / 16449 (2.7%) | 13336 / 164490 (8.1%) | −173.2 | −171.3 | 0.33 |
| Epitope tags SRX7276679 | 293 Kidney | 1928 / 16449 (11.7%) | 9254 / 164490 (5.6%) | −173.0 | −171.1 | 2.08 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 431 / 16449 (2.6%) | 13096 / 164490 (8.0%) | −172.8 | −170.9 | 0.33 |
| KMT2A SRX20870810 | SEM Blood | 1566 / 16449 (9.5%) | 6792 / 164490 (4.1%) | −172.7 | −170.8 | 2.31 |
| KAT6A SRX20971022 | Fibroblasts Others | 235 / 16449 (1.4%) | 80 / 164490 (0.0%) | −172.4 | −170.5 | 29.38 |
| RYBP SRX3256865 | hESC H1 Pluripotent stem cell | 1439 / 16449 (8.7%) | 5969 / 164490 (3.6%) | −172.4 | −170.5 | 2.41 |
| Epitope tags SRX20777238 | ASPS1 Lung | 1530 / 16449 (9.3%) | 6561 / 164490 (4.0%) | −172.4 | −170.5 | 2.33 |
| Crotonyllysine SRX12306536 | Polycystic kidney Kidney | 1563 / 16449 (9.5%) | 6783 / 164490 (4.1%) | −172.1 | −170.3 | 2.30 |
| XPO1 SRX14127501 | OCI-AML3 Blood | 542 / 16449 (3.3%) | 1024 / 164490 (0.6%) | −172.1 | −170.2 | 5.29 |
| MYC SRX250091 | MDA-MB-453 Breast | 2093 / 16449 (12.7%) | 10452 / 164490 (6.4%) | −172.0 | −170.2 | 2.00 |
| MethylCap SRX014766 | NB-4 Blood | 1569 / 16449 (9.5%) | 6826 / 164490 (4.1%) | −171.9 | −170.1 | 2.30 |
| RTF1 SRX15147196 | DLD-1 Digestive tract | 704 / 16449 (4.3%) | 1750 / 164490 (1.1%) | −171.9 | −170.0 | 4.02 |
| BRD4 SRX5729951 | 22Rv1 Prostate | 1024 / 16449 (6.2%) | 3444 / 164490 (2.1%) | −171.7 | −169.9 | 2.97 |
| DDX21 SRX8257415 | A-375 Epidermis | 960 / 16449 (5.8%) | 3087 / 164490 (1.9%) | −171.6 | −169.7 | 3.11 |
| YAP1 SRX10119364 | MCF 10A Breast | 259 / 16449 (1.6%) | 10140 / 164490 (6.2%) | −171.4 | −169.6 | 0.26 |
| KDM2B SRX1787312 | OCI-LY1 Blood | 1734 / 16449 (10.5%) | 7954 / 164490 (4.8%) | −171.1 | −169.2 | 2.18 |
| JUND SRX150408 | HeLa Uterus | 276 / 16449 (1.7%) | 10430 / 164490 (6.3%) | −171.0 | −169.1 | 0.26 |
| FOS SRX3322636 | MCF-7 Breast | 194 / 16449 (1.2%) | 8916 / 164490 (5.4%) | −170.6 | −168.8 | 0.22 |
| FOXA1 SRX4815197 | MCF-7 Breast | 848 / 16449 (5.2%) | 19259 / 164490 (11.7%) | −170.6 | −168.7 | 0.44 |
| STAT5A SRX9681370 | ARP-1 Blood | 1060 / 16449 (6.4%) | 3673 / 164490 (2.2%) | −170.3 | −168.4 | 2.89 |
| ZFX SRX3091902 | MCF-7 Breast | 999 / 16449 (6.1%) | 3326 / 164490 (2.0%) | −170.0 | −168.2 | 3.00 |
| YAP1 SRX1038945 | IMR-90 Lung | 226 / 16449 (1.4%) | 9498 / 164490 (5.8%) | −170.0 | −168.1 | 0.24 |
| PBX3 SRX190343 | SK-N-SH Neural | 723 / 16449 (4.4%) | 17437 / 164490 (10.6%) | −169.8 | −167.9 | 0.41 |
| Epitope tags SRX6366606 | Ishikawa Uterus | 1982 / 16449 (12.0%) | 9713 / 164490 (5.9%) | −169.7 | −167.8 | 2.04 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 1118 / 16449 (6.8%) | 4023 / 164490 (2.4%) | −169.6 | −167.7 | 2.78 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 619 / 16449 (3.8%) | 1375 / 164490 (0.8%) | −169.5 | −167.7 | 4.50 |
| FOXA1 SRX1161177 | MCF-7 Breast | 348 / 16449 (2.1%) | 11624 / 164490 (7.1%) | −169.5 | −167.7 | 0.30 |
| CSTF2 SRX10722980 | U2OS Bone | 798 / 16449 (4.9%) | 2243 / 164490 (1.4%) | −169.4 | −167.6 | 3.56 |
| ARID2 SRX4473693 | BIN-67 Gonad | 1286 / 16449 (7.8%) | 5052 / 164490 (3.1%) | −169.3 | −167.4 | 2.55 |
| KMT2A SRX14127515 | OCI-AML3 Blood | 1105 / 16449 (6.7%) | 3953 / 164490 (2.4%) | −169.1 | −167.2 | 2.80 |
| SUPT5H SRX7677724 | DLD-1 Digestive tract | 1575 / 16449 (9.6%) | 6922 / 164490 (4.2%) | −169.1 | −167.2 | 2.28 |
| EZH2 SRX317569 | iPS cells Pluripotent stem cell | 1468 / 16449 (8.9%) | 6220 / 164490 (3.8%) | −168.9 | −167.1 | 2.36 |
| SUPT6H SRX15147167 | DLD-1 Digestive tract | 1318 / 16449 (8.0%) | 5259 / 164490 (3.2%) | −168.9 | −167.0 | 2.51 |
| FGFR1 SRX8246294 | MCF-7 Breast | 1074 / 16449 (6.5%) | 3774 / 164490 (2.3%) | −168.8 | −166.9 | 2.85 |
| PRRX1 SRX15235713 | Hs 578T Breast | 400 / 16449 (2.4%) | 12445 / 164490 (7.6%) | −168.4 | −166.5 | 0.32 |
| HDAC1 SRX18517813 | Keratinocytes Epidermis | 867 / 16449 (5.3%) | 2620 / 164490 (1.6%) | −168.2 | −166.3 | 3.31 |
| MED1 SRX5236337 | HUVEC Cardiovascular | 589 / 16449 (3.6%) | 1253 / 164490 (0.8%) | −168.1 | −166.3 | 4.70 |
| EP300 SRX359404 | 293 Kidney | 954 / 16449 (5.8%) | 3098 / 164490 (1.9%) | −168.1 | −166.3 | 3.08 |
| SMARCA4 SRX5212362 | Mel270 Others | 596 / 16449 (3.6%) | 15492 / 164490 (9.4%) | −168.0 | −166.1 | 0.38 |
| ZNF384 SRX17159338 | JIH-5 Blood | 1881 / 16449 (11.4%) | 9045 / 164490 (5.5%) | −167.8 | −165.9 | 2.08 |
| KDM5B SRX3285589 | C70R Breast | 750 / 16449 (4.6%) | 2017 / 164490 (1.2%) | −167.7 | −165.9 | 3.72 |
| SMARCA4 SRX5212371 | Mel270 Others | 480 / 16449 (2.9%) | 13693 / 164490 (8.3%) | −167.5 | −165.6 | 0.35 |
| BRD4 SRX13134686 | 293 Kidney | 1178 / 16449 (7.2%) | 4422 / 164490 (2.7%) | −167.0 | −165.1 | 2.66 |
| JUN SRX2355072 | HAEC Cardiovascular | 443 / 16449 (2.7%) | 13080 / 164490 (8.0%) | −166.7 | −164.9 | 0.34 |
| NR1D1 SRX23813276 | C4-2B Prostate | 1296 / 16449 (7.9%) | 5163 / 164490 (3.1%) | −166.4 | −164.6 | 2.51 |
| SAP30 SRX17989898 | MDA-MB-231 Breast | 1541 / 16449 (9.4%) | 6751 / 164490 (4.1%) | −166.3 | −164.4 | 2.28 |
| SMARCA4 SRX7951331 | NCI-H1944 Lung | 1102 / 16449 (6.7%) | 3985 / 164490 (2.4%) | −165.8 | −164.0 | 2.77 |
| CPSF3 SRX8018228 | 293 Kidney | 882 / 16449 (5.4%) | 2737 / 164490 (1.7%) | −165.2 | −163.4 | 3.22 |
| ETS1 SRX9046311 | THP-1 Blood | 1110 / 16449 (6.7%) | 4045 / 164490 (2.5%) | −165.0 | −163.2 | 2.74 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 796 / 16449 (4.8%) | 18287 / 164490 (11.1%) | −164.7 | −162.8 | 0.44 |
| ESR1 SRX371476 | MCF-7 Breast | 255 / 16449 (1.6%) | 9857 / 164490 (6.0%) | −164.5 | −162.7 | 0.26 |
| ESR1 SRX371469 | MCF-7 Breast | 372 / 16449 (2.3%) | 11852 / 164490 (7.2%) | −164.3 | −162.5 | 0.31 |
| AR SRX5286309 | LNCAP Prostate | 2140 / 16449 (13.0%) | 10987 / 164490 (6.7%) | −164.3 | −162.4 | 1.95 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 374 / 16449 (2.3%) | 11879 / 164490 (7.2%) | −164.1 | −162.3 | 0.31 |
| ZFX SRX3322358 | MCF-7 Breast | 991 / 16449 (6.0%) | 3363 / 164490 (2.0%) | −163.8 | −162.0 | 2.95 |
| ESR1 SRX2897208 | Breast cancer cells Breast | 2926 / 16449 (17.8%) | 16983 / 164490 (10.3%) | −163.4 | −161.5 | 1.72 |
| ESR1 SRX371479 | MCF-7 Breast | 328 / 16449 (2.0%) | 11072 / 164490 (6.7%) | −162.9 | −161.1 | 0.30 |
| FOXA2 SRX266856 | hESC derived mesendodermal cells Pluripotent stem cell | 1845 / 16449 (11.2%) | 8938 / 164490 (5.4%) | −161.5 | −159.7 | 2.06 |
| ETV6 SRX11661400 | EW-8 Bone | 1940 / 16449 (11.8%) | 9612 / 164490 (5.8%) | −161.5 | −159.6 | 2.02 |
| CDK9 SRX20230569 | Ishikawa Uterus | 2129 / 16449 (12.9%) | 10980 / 164490 (6.7%) | −161.4 | −159.6 | 1.94 |
| Epitope tags SRX9034605 | VCaP Prostate | 1078 / 16449 (6.6%) | 3908 / 164490 (2.4%) | −161.3 | −159.5 | 2.76 |
| ETV6 SRX11661399 | EW-8 Bone | 1875 / 16449 (11.4%) | 9156 / 164490 (5.6%) | −161.3 | −159.5 | 2.05 |
| FOXA1 SRX371482 | MCF-7 Breast | 527 / 16449 (3.2%) | 14202 / 164490 (8.6%) | −161.3 | −159.4 | 0.37 |
| HOXB13 SRX10372586 | C4-2B Prostate | 1793 / 16449 (10.9%) | 8581 / 164490 (5.2%) | −161.2 | −159.4 | 2.09 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 234 / 16449 (1.4%) | 9376 / 164490 (5.7%) | −161.2 | −159.3 | 0.25 |
| JUNB SRX8488089 | SUM 229PE Breast | 341 / 16449 (2.1%) | 11226 / 164490 (6.8%) | −161.0 | −159.2 | 0.30 |
| KMT2A SRX2323895 | 293 Kidney | 420 / 16449 (2.6%) | 623 / 164490 (0.4%) | −160.9 | −159.1 | 6.74 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 276 / 16449 (1.7%) | 10103 / 164490 (6.1%) | −160.5 | −158.7 | 0.27 |
| AR SRX1067071 | LHSAR Prostate | 707 / 16449 (4.3%) | 16849 / 164490 (10.2%) | −160.4 | −158.6 | 0.42 |
Showing first 500 of 18081 rows.